Abiomed, Inc. (ABMD) Posts Surprise Q4 Profit; Guides FY12 Revs Above
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Join SI Premium – FREE
Abiomed, Inc. (Nasdaq: ABMD) reported Q4 EPS of $0.01, $0.05 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.71 million.
Sees FY12 revenue of $120 - $125 million, versus the consensus of $119.36 million.
Sees FY12 revenue of $120 - $125 million, versus the consensus of $119.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Avino Silver & Gold Mines (ASM) Misses Q2 EPS by 4c
- Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
